| Enviage |
Human |
aliskiren |
aliskiren |
EMEA/H/C/000850 |
Novartis Europharm Ltd. |
2007/08/22
|
Withdrawn |
| Tekturna |
Human |
aliskiren |
aliskiren |
EMEA/H/C/000852 |
Novartis Europharm Ltd. |
2007/08/22
|
Withdrawn |
| Increlex |
Human |
mecasermin |
Mecasermin |
EMEA/H/C/000704 |
Esteve Pharmaceuticals, S.A. |
2007/08/02
|
Authorised |
| Aerinaze |
Human |
desloratadine;pseudoephedrine |
desloratadine;pseudophedrine sulfate |
EMEA/H/C/000772 |
N.V. Organon |
2007/07/30
|
Authorised |
| Flebogamma DIF (previously Flebogammadif) |
Human |
human normal immunoglobulin |
human normal immunoglobulin |
EMEA/H/C/000781 |
Instituto Grifols S.A. |
2007/07/23
|
Authorised |
| Optimark |
Human |
gadoversetamide |
gadoversetamide |
EMEA/H/C/000745 |
Mallinckrodt Deutschland GmbH |
2007/07/23
|
Withdrawn |
| Alli (previously Orlistat GSK) |
Human |
orlistat |
orlistat |
EMEA/H/C/000854 |
Haleon Ireland Dungarvan Limited |
2007/07/22
|
Authorised |
| Mircera |
Human |
methoxy polyethylene glycol-epoetin beta |
Methoxy polyethylene glycol-epoetin beta |
EMEA/H/C/000739 |
Roche Registration GmbH |
2007/07/20
|
Authorised |
| Siklos |
Human |
hydroxycarbamide |
hydroxycarbamide |
EMEA/H/C/000689 |
Theravia |
2007/06/29
|
Authorised |
| Circadin |
Human |
melatonin |
melatonin |
EMEA/H/C/000695 |
RAD Neurim Pharmaceuticals EEC SARL |
2007/06/29
|
Authorised |
| Pergoveris |
Human |
follitropin alfa;lutropin alfa |
follitropin alfa;lutropin alfa |
EMEA/H/C/000714 |
Merck Europe B.V. |
2007/06/25
|
Authorised |
| Invega |
Human |
paliperidone |
paliperidone |
EMEA/H/C/000746 |
Janssen-Cilag International NV |
2007/06/24
|
Authorised |
| Soliris |
Human |
eculizumab |
Eculizumab |
EMEA/H/C/000791 |
|
2007/06/20
|
Authorised |
| Spironolactone Ceva |
Veterinary |
spironolactone |
spironolactone |
EMEA/V/C/000105 |
Ceva Santé Animale |
2007/06/20
|
Withdrawn |
| Revlimid |
Human |
lenalidomide |
lenalidomide |
EMEA/H/C/000717 |
Bristol-Myers Squibb Pharma EEIG |
2007/06/14
|
Authorised |
| Optaflu |
Human |
influenza vaccine (surface antigen, inactivated, prepared in cell cultures) |
influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain(A/Brisbane/10/2010, wild type)A/Switzerland/9715293/2013 (H3N2) - like strain(A/South Australia/55/2014, wild type)B/Phuket/3073/2013–like strain(B/Utah/9/2014, wild type) |
EMEA/H/C/000758 |
Seqirus GmbH |
2007/06/01
|
Expired |
| Altargo |
Human |
retapamulin |
retapamulin |
EMEA/H/C/000757 |
Glaxo Group Ltd |
2007/05/24
|
Withdrawn |
| Orencia |
Human |
abatacept |
abatacept |
EMEA/H/C/000701 |
Bristol-Myers Squibb Pharma EEIG |
2007/05/21
|
Authorised |
| Nobilis Influenza H7N1 |
Veterinary |
adjuvanted inactivated vaccine against avian influenza virus type A, subtype H7 |
inactivated whole avian influenza virus antigen of H7N1 subtype (strain, A/CK/Italy/473/99) |
EMEA/V/C/000123 |
Intervet International BV |
2007/05/14
|
Withdrawn |
| Focetria |
Human |
influenza vaccine H1N1v (surface antigen, inactivated, adjuvanted) |
Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/California/7/2009 (H1N1)-derived strain used NYMC X-181 |
EMEA/H/C/000710 |
Novartis Vaccines and Diagnostics S.r.l. |
2007/05/02
|
Expired |